Ciapponi, A., Bardach, A., Colaci, C., Rodríguez Cairoli, F., Argento, F., Korbenfeld, E., & García Martí, S. (2024). Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER2 positive breast cancer: systematic review and network meta-analysis. Revista Peruana De Medicina Experimental Y Salud Pública, 41(1), 7-18. https://doi.org/10.17843/rpmesp.2024.411.13351